Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Roku raises streaming stick prices by up to 60 percent

    July 25, 2026

    China fines Trip.com $700 million for abusing online travel dominance

    July 25, 2026

    1 hyperscaler megacap down, 3 to go. Alphabet raises the stakes on AI spending

    July 25, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Tech»RFK Jr. won’t back CDC director on vaccines as agency scraps positive data
    Tech

    RFK Jr. won’t back CDC director on vaccines as agency scraps positive data

    franperez66q@protonmail.comBy franperez66q@protonmail.comApril 23, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    Kennedy replied without hesitation: “I’m not going to make that kind of commitment.”

    “Because you probably won’t,” Ruiz said. “You’ll probably fire her, too, like you did director Monarez, because you will not accept the recommendations based on science.”

    Suppressed science

    A report from the Washington Post on Wednesday seemed to support Ruiz’s concern for Kennedy’s continued anti-vaccine interference. The Post reported that the CDC has decided to entirely scrap a scientifically vetted study that identified significant health benefits from the 2025–2026 COVID-19 vaccine. While Kennedy has called COVID-19 vaccines the “deadliest vaccine ever made,” the study found that the shot reduced the risk of emergency department or urgent care visits by 50 percent, and reduced the risk of COVID-19-associated hospitalizations by 55 percent, compared with healthy adults who did not get this season’s shot.

    The study had previously cleared scientific review and was set for publication in the agency’s Morbidity and Mortality Weekly Report on March 19. But the study was instead held up by acting CDC director Jay Bhattacharya, who said he had concerns about the study’s methods. The study used a standard, widely accepted design. A flu vaccine study using the same design was published in the MMWR earlier in March.

    Last month, Andrew Nixon, spokesperson for the Department of Health and Human Services, said that CDC scientists were working to address Bhattacharya’s concerns. But this week, Nixon told the Post that an “editorial assessment identified concerns regarding the methodological approach to estimating vaccine effectiveness and the manuscript was not accepted for publication.”

    The Post’s sources said that was not an accurate account of what happened.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Roku raises streaming stick prices by up to 60 percent

    July 25, 2026

    1 hyperscaler megacap down, 3 to go. Alphabet raises the stakes on AI spending

    July 25, 2026

    Paramount/WBD merger delayed for months as states’ lawsuit moves toward trial

    July 25, 2026

    Bond market anxiety is growing over AI capex budgets

    July 25, 2026

    Wildfire forces evacuation of NASA’s Deep Space Network complex in Spain

    July 25, 2026

    SpaceX launches massive Starship rocket in first test flight since IPO

    July 25, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    Roku raises streaming stick prices by up to 60 percent

    July 25, 2026

    China fines Trip.com $700 million for abusing online travel dominance

    July 25, 2026

    1 hyperscaler megacap down, 3 to go. Alphabet raises the stakes on AI spending

    July 25, 2026

    Paramount/WBD merger delayed for months as states’ lawsuit moves toward trial

    July 25, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.